Cargando…
SAT-465 Somatostatin Receptor Ligand as Initial Therapy in a Patient with Pituitary Microadenoma and Acromegaly: Temporary Remission and Recurrence
BACKGROUND: Transsphenoidal surgery is recommended as initial therapy for microadenomas causing acromegaly. Primary medical therapy with somatostatin analogues has shown to cause a reduction in the size of microadenomas and secretion of growth hormone. Normalization of IGF-1 levels with somatostatin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552506/ http://dx.doi.org/10.1210/js.2019-SAT-465 |